drugset / Trial / NCT02608177
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
Completed
3 enrolled
University of Washington
Abbott · collabAmerican Diabetes Association · collabMedtronic · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The goal of this study is to test whether a dipeptidyl peptidase-4 inhibitor, compared with a sulfonylurea, improves time in normal blood glucose range and reduces blood glucose variability. Blood glucose is measured using a continuous glucose monitoring device.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-08
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glipizide | Small molecule | — | — |
| Subject | Linagliptin | Small molecule | — | — |